CDER Regulatory Science Research (RSR) Projects AI for Process Control in Advanced Manufacturing
Department of Health and Human Services · HHS/FDA/CDER
Overview
- Development stage
- DeployedSource: c) Deployed – The use case is being actively authorized or utilized to support the functions or mission of an agency.
- High-impact designation
- Presumed high-impact, determined notSource: b) Presumed high-impact, but determined not high impact
- Impact justification
- This project explores the use of AI in advanced pharmaceutical manufacturing as part of an exploratory R&D effort focused on model predictive control strategies. The AI components are used solely in a research context to improve understanding of AI-enabled control systems and inform future regulatory readiness. The project does not involve operational use, decision-making, or direct impact on the public or regulated entities. Therefore, it does not meet the definition of a high-impact AI use case under OMB M-25-21.
- Start date
- 2024-07 (month precision)Source: Jul-24
- Withheld from public reporting
- NoSource: a) No
Mission
- Topic area
- Science
- Operational functions
- No function tag matched Derived by keyword rules; see methodology
Problem the AI is intended to solve
Need for better process control in continuous manufacturing and development of soft sensors for real-time release testing strategies.
Expected benefits
The outcomes of this work can be used to gain a better understanding of AI in advanced pharmaceutical manufacturing control, identify the associated risks, and help review future submissions involving this technology, ultimately supporting more efficient and reliable drug manufacturing.
System outputs
The AI model demonstrated remarkable performance in setpoint tracking and disturbance rejection for a digital continuous manufacturing line, underscoring the potential of AI-based control strategies in enhancing product quality and regulatory assessment.
Technology
- AI classification
- Classical / predictive MLSource: Classical/Predictive Machine Learning: Models trained on data to make predictions or classifications based on identified patterns or relatio…
- System name(s)
- Not reported
- Custom-developed code
- Yes
- Public source code
- Not reported
Sourcing
- How it was built
- Developed in-houseSource: b) Developed in-house
- Vendor (as reported)
- Not reported
- Vendors (standardized)
- None on the standard list
A vendor is the supplier named by the agency. It does not identify the underlying model or AI technology.
Data and privacy
- Involves PII
- No
- Privacy Impact Assessment
- Not reported
- Authorization to Operate
- No
- Demographic features
- k) None of the above
- Training and evaluation data
- Data was generated using a digital twin of a manufacturing plant developed in-house
- Federal Data Catalog
- Not reported
Governance
0 of 8 minimum-practice questions answered. A blank answer means the agency reported nothing; it does not mean the practice is absent.
Potential impacts and how they were identified
Not reported